Correction: Hybrid thiazolyl–benzylidene–phenol metal complexes as novel chemotherapeutic agents with anti-topoisomerase I activity in human breast carcinoma: synthesis, in vitro and in silico studies

TL;DR

This paper corrects a previous study on new metal complexes that may help treat breast cancer by targeting an enzyme involved in DNA repair.

Contribution

The paper provides a correction to prior research on the synthesis and testing of novel metal complexes for breast cancer treatment.

Findings

The corrected study details the synthesis of hybrid thiazolyl–benzylidene–phenol metal complexes.

These complexes show anti-topoisomerase I activity, which is relevant for cancer therapy.

In vitro and in silico studies support their potential as chemotherapeutic agents.

Abstract

Correction for ‘Hybrid thiazolyl–benzylidene–phenol metal complexes as novel chemotherapeutic agents with anti-topoisomerase I activity in human breast carcinoma: synthesis, in vitro and in silico studies’ by Ahmed M. Alharbi et al., RSC Adv., 2025, 15, 20552–20569, https://doi.org/10.1039/D5RA00889A.